IDENTIFICATION OF NEW HIV-1 PROTEASE INHIBITORS BY MULTIPLE LINEAR REGRESSION (MLR) AND PHYSICO-CHEMICAL DESCRIPTORS

被引:0
|
作者
Nandan, Kumar [1 ]
Ahmad, Md. Belal [1 ]
Ranjan, Kumar [3 ]
Sah, Baidyanath [2 ]
机构
[1] TM Bhagalpur Univ, TNB Coll, Dept Chem, Bhagalpur 812007, Bihar, India
[2] TM Bhagalpur Univ, TNB Coll, Dept Math, Bhagalpur 812007, Bihar, India
[3] Barkatullah Univ, Dept Chem, Bhopal, Madhya Pradesh, India
关键词
QSAR; MFA; HIV-1; activity; MLR; QSPR;
D O I
10.13040/IJPSR.0975-8232.4(10).3971-75
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present work in mathematical modeling, quantitative structure activity relationship (QSAR) studies were performed on some 5, 6-dihydro-2-pyrones derivatives using statistical work. Using only 4 topological and physico-chemical molecular descriptors, we have achieved 84.81% correct classification of the compounds with and without its activity. A heurisimatedtic algorithm selects the best multiple linear regression(MLR) equation showed the correlation between the observed values and the estimated values of activity is very good(R=0.9209, R-2 =O.8481, PRESS=0.7312, R-cv(2)= 0.8210, S-PRESS = 0.2074). The results are discussed in the light of the main factors that influence the inhibitory activity of the HIV-1 protease.
引用
收藏
页码:3971 / 3975
页数:5
相关论文
共 50 条
  • [1] Design of new inhibitors of HIV-1 aspartic protease
    Miertus, S
    Furlan, M
    Tossi, A
    Romeo, D
    CHEMICAL PHYSICS, 1996, 204 (2-3) : 173 - 180
  • [2] Identification physico-chemical properties and immunochemical, characteristic of prostate specific antigen and its complexes with protease inhibitors
    Chekhonin, VP
    Mazo, EB
    Rjabukhin, IA
    Grigorev, ME
    VOPROSY MEDITSINSKOI KHIMII, 1997, 43 (03): : 165 - 171
  • [3] Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition
    Judd, DA
    Nettles, JH
    Nevins, N
    Snyder, JP
    Liotta, DC
    Tang, J
    Ermolieff, J
    Schinazi, RF
    Hill, CL
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (05) : 886 - 897
  • [4] Computational drug design of new HIV-1 protease inhibitors
    Lebon, F
    Vinals, C
    Feytmans, E
    Durant, F
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 1996, 104 (03) : B44 - B44
  • [5] Design of new HIV-1 protease inhibitors by pharmacophore searching
    Chen, HF
    Yuan, SG
    Luo, SW
    Dong, XC
    Yao, JH
    Yang, S
    Zheng, CZ
    ACTA CHIMICA SINICA, 2000, 58 (03) : 287 - 292
  • [6] Tricyclic ureas: A new class of HIV-1 protease inhibitors
    Han, W
    Pelletier, JC
    Hodge, CN
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) : 3615 - 3620
  • [7] QSAR Studies on HIV-1 Protease Inhibitors Using Non-Linearly Transformed Descriptors
    Saranya, Nallusamy
    Selvaraj, Samuel
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2012, 8 (01) : 10 - 49
  • [8] PROGRESS TOWARDS NEW CONFORMATIONALLY CONSTRAINED HIV-1 PROTEASE INHIBITORS
    BENATALAH, Z
    TRIGUI, N
    SICSIC, S
    TONNAIRE, T
    DEROSNY, E
    BOGGETTO, N
    REBOUD, M
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (11) : 891 - 900
  • [9] New peptides and triterpene derivatives as dimerization inhibitors of HIV-1 protease
    Schramm, Hans J.
    Quere, Luc
    Schramm, Wolfgang
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 163 - 163
  • [10] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
    CONDRA, JH
    SCHLEIF, WA
    BLAHY, OM
    GABRYELSKI, LJ
    GRAHAM, DJ
    QUINTERO, JC
    RHODES, A
    ROBBINS, HL
    ROTH, E
    SHIVAPRAKASH, M
    TITUS, D
    YANG, T
    TEPPLER, H
    SQUIRES, KE
    DEUTSCH, PJ
    EMINI, EA
    NATURE, 1995, 374 (6522) : 569 - 571